Apyx Medical

Yahoo Finance • 10 days ago

New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®

CLEARWATER, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics products marketed and sold as Renuvion® and the AYON Body Contouring System™... Full story

Yahoo Finance • 23 days ago

Apyx Medical (APYX) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATE Thursday, May 7, 2026 at 8 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Charles D. Goodwin Chief Financial Officer — Matthew Hill Full Conference Call Transcript Charles Goodwi... Full story

Yahoo Finance • 24 days ago

Apyx Medical Q1 Earnings Call Highlights

Apyx Medical logo Key Points Apyx reported Q1 revenue of $12.5 million (up from $9.4M), driven by the commercial ramp of the AYON body‑contouring system and a 36% increase in Surgical Aesthetics to $10.7 million, and management raised fu... Full story

Yahoo Finance • 6 months ago

AI adopters trade gaining steam; top stocks in AI adoption sectors

[Digital Intelligence - AI Icon Illuminated Against Financial Data and Binary Streams] J Studios Wall Street research looks to be shifting from endorsing the classic AI trade to AI adopters. Instead of the chipmakers and hyperscalers in... Full story

Yahoo Finance • 6 months ago

Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea

CLEARWATER, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), t... Full story

Yahoo Finance • 6 months ago

Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock

CLEARWATER, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), t... Full story

Yahoo Finance • 6 months ago

Apyx Medical Corporation Announces Proposed Public Offering of Common Stock

CLEARWATER Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), to... Full story

Yahoo Finance • 7 months ago

Ken Fisher's Strategic Moves: iShares 7-10 Year Treasury Bond ETF Takes Center Stage

This article first appeared on GuruFocus. Exploring Ken Fisher (Trades, Portfolio)'s Latest 13F Filing for Q3 2025 Warning! GuruFocus has detected 7 Warning Signs with NVDA. Is NVDA fairly valued? Test your thesis with our free DCF calcu... Full story

Yahoo Finance • 10 months ago

Apyx Medical outlines $50M–$52M 2025 revenue targets as AYON presales surpass expectations and China launch advances

Earnings Call Insights: Apyx Medical Corporation (APYX) Q2 2025 MANAGEMENT VIEW * Charles D. Goodwin, President and CEO, announced the appointment of two senior sales leaders: "John Featherstone will head North American sales and has o... Full story

Yahoo Finance • 10 months ago

Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”) today announced that on August 4, 2025, Apyx granted a nonstatuatory stock option to purchase 100,000 shares of co... Full story

Yahoo Finance • 10 months ago

Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference

CLEARWATER, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and... Full story

Yahoo Finance • 10 months ago

Apyx Medical launches Renuvion in China through distribution deal

CLEARWATER, Fla. - Apyx Medical Corporation (NASDAQ:APYX), a $96 million market cap medical device company whose stock has surged nearly 90% over the past year, announced Monday the launch of its Renuvion technology in China following init... Full story

Yahoo Finance • 10 months ago

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025

CLEARWATER, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and... Full story

Yahoo Finance • last year

Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™

The AYON Body Contouring System is the first FDA cleared all-in-one platform for the aesthetic surgical suite Plan to initiate the commercial launch of the AYON Body Contouring System to key opinion leader surgeons in critical geographies... Full story

Yahoo Finance • 3 years ago

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2023 Financial Results on August 10, 2023

CLEARWATER, Fla., June 29, 2023--(BUSINESS WIRE)--Apyx® Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that f... Full story

Yahoo Finance • 3 years ago

Apyx Medical Corporation Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook

CLEARWATER, Fla., May 11, 2023--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today reported financial... Full story

Yahoo Finance • 3 years ago

Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of the Renuvion® APR Handpiece for the Coagulation of Subcutaneous Soft Tissues Where Needed, Following Liposuction

CLEARWATER, Fla., February 01, 2023--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced it... Full story

Yahoo Finance • 4 years ago

Apyx Medical Corporation Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook

CLEARWATER, Fla., August 11, 2022--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today reported financ... Full story

Yahoo Finance • 4 years ago

DEADLINE ALERT for APYX, VRCA, APPS, TDOC: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

BENSALEM, Pa., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the d... Full story

Yahoo Finance • 4 years ago

APYX 最終截止日期星期五：頂尖的律師事務所 ROSEN 鼓勵蒙受虧損的 Apyx Medical Corporation 投資者在證券集體訴訟的重要截止日期8 月 5 日前尋求法律意見 – APYX

紐約, Aug. 03, 2022 (GLOBE NEWSWIRE) -- 為何： 全球投資者權益律師事務所 Rosen Law Firm 提醒在 2021 年 5 月 12 日至 2022 年 3 月 11 日（包括首尾兩天）期間（「集體訴訟期間」）購買 Apyx Medical Corporation (NASDAQ: APYX) 證券的購買者注意，2022 年 8 月 5 日是首席原告人截止日期的重要日子。 何事：如果您在集體訴訟期間購買了 Apyx 證券，您可... Full story